The Canadian Fontan Connection (CANFON): Protocol for a National Lifespan Cohort of People Living With a Fontan

Louis-Olivier Roy1, Marc-Olivier Pouliot1, Reena Clarkson2

  • 1Department of Pediatrics, Université de Sherbrooke, and Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.

Insights

The Canadian Fontan Connection (CANFON) cohort study tracks individuals with Fontan circulation to understand long-term health, complications, and quality of life. This national research platform aims to improve outcomes for this growing population.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Congenital Heart Disease Research

Background:

  • Life expectancy for individuals with Fontan circulation has increased, but they face risks of multiorgan complications and premature death.
  • Significant knowledge gaps persist regarding the timing, progression, and cumulative burden of Fontan-related morbidity and its impact on quality of life.
  • Understanding long-term outcomes is crucial for managing this unique patient population.

Purpose of the Study:

  • To establish lifelong health trajectories for individuals with Fontan physiology.
  • To determine the prevalence, evolution, and risk factors of complications associated with Fontan circulation.
  • To assess the impact of complications on quality of life and functional status using participant-reported outcomes.

Main Methods:

  • Establishment of the Canadian Fontan Connection (CANFON), a national, longitudinal cohort study.
  • Comprehensive lifelong clinical data collection from birth, including participant-reported outcomes over 5 years.
  • Recruitment across 24 pediatric and adult congenital heart disease centers in Canada.

Main Results:

  • The CANFON cohort is established, enrolling individuals with single ventricle physiology and Fontan circulation.
  • A comprehensive dataset is being collected to track health trajectories and complications.
  • Participant-reported outcomes are being prospectively gathered to evaluate quality of life and functional status.

Conclusions:

  • CANFON provides a robust platform for understanding and improving lifelong outcomes for individuals with Fontan circulation.
  • The study will identify predictors of Fontan failure and the impact of complications on patient well-being.
  • This research will contribute valuable insights to national and international efforts in congenital heart disease management.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753